logo

ENTX

Entera BioยทNASDAQ
--
--(--)
--
--(--)

ENTX Profile

Entera Bio Ltd.

A clinical-stage biopharmaceutical company that developing orally delivered large molecule therapeutics

Pharmaceutical
09/30/2009
06/28/2018
NASDAQ Stock Exchange
20
12-31
Common stock
Kiryat Hadassah, Minrav Building - Fifth Floor, Jerusalem , Israel 9112002
--
Entera Bio Ltd., was incorporated on September 30, 2009 and commenced operations on June 1, 2010. The company is a clinical-stage company focused on developing first-in-class oral tablet forms of peptide or protein replacement therapies. The company focuses on underserved chronic conditions, and oral protein therapy has the potential to change the treatment model.